Abstract
An efficient synthesis of diltiazem has been developed using dynamic kinetic resolution
(DKR) as a key step. The methyl (2S ,3S )-2-chloro-3-hydroxy-3-(4-methoxyphenyl)propionate was synthesized from a racemic
mixture of α-chloro-β-keto ester, with high anti diastereoselectivity (92%) and enantioselectivity (95%), based on an asymmetric hydrogenation
reaction with a chiral ruthenium(II) catalyst, simply prepared by mixing Ru(cod)(2-methylallyl)2 with the atropisomeric ligand (S )-MeO-BIPHEP. By treatment of this α-chloro-β-hydroxy ester with a base, the corresponding
trans methyl glycidate, a key intermediate of diltiazem, was easily obtained.
Key words
Diltiazem - drugs - kinetic resolution - asymmetric catalysis - hydrogenations - ruthenium
References <A NAME="RZ09403SS-1">1 </A>
Centro de Ciências Exatas e Naturais, Universidade Federal de Alagoas, Campus A.C.
Simões, Tabuleiro do Martins, 57072-970, Maceió, Brasil.
<A NAME="RZ09403SS-2">2 </A>
Laboratoire de Synthèse Organique Asymétrique et Catalyse Homogène, 01 UR 1201, Facultés
des Sciences de Monastir, Avenue de l’Environnement, 5019 Monastir, Tunisie.
<A NAME="RZ09403SS-3A">3a </A>
Nagao T.
Sato M.
Nakajima H.
Kiyomoto A.
Chem. Pharm. Bull.
1973,
21:
92
<A NAME="RZ09403SS-3B">3b </A>
Yasue H.
Omote S.
Takizawa A.
Nagao T.
Circ. Res. Suppl.1
1983,
52
<A NAME="RZ09403SS-4A">4a </A>
Bousquet A,
Dormoy J.-R, and
Heymes A. inventors; Sanofi, Patent EP 040912.
<A NAME="RZ09403SS-4B">4b </A>
Chang S.
Galvin JM.
Jacobsen EN.
J. Am. Chem. Soc.
1994,
116:
6937
<A NAME="RZ09403SS-4C">4c </A>
Wang Z.-X.
Shi Y.
J. Org. Chem.
1997,
62:
8622
<A NAME="RZ09403SS-4D">4d </A>
Adger BM.
Barkley JV.
Bergeron S.
Cappi MW.
Flowerdew BE.
Jackson MP.
McCague R.
Nugent TC.
Roberts SM.
J. Chem. Soc., Perkin Trans. 1
1997,
3501
<A NAME="RZ09403SS-4E">4e </A>
Armstrong A.
Hayter BR.
Chem. Commun.
1998,
621
<A NAME="RZ09403SS-4F">4f </A>
Solladie-Cavallo A.
Bouerat L.
Jierry L.
Eur. J. Org. Chem.
2001,
66:
4557
<A NAME="RZ09403SS-4G">4g </A>
Seki M.
Furutani T.
Imashiro R.
Kuroda T.
Yamanaka T.
Harada N.
Arakawa H.
Kusama M.
Hashiyama T.
Tetrahedron Lett.
2001,
42:
8201
<A NAME="RZ09403SS-4H">4h </A>
Furutani T.
Imashiro R.
Hatsuda M.
Seki M.
J. Org. Chem.
2002,
67:
4599
<A NAME="RZ09403SS-5">5 </A>
Imashiro R.
Kuroda T.
J. Org. Chem.
2003,
68:
974
<A NAME="RZ09403SS-6A">6a </A>
Schwartz A.
Madan PB.
Mohacsi E.
O’Brien JP.
Todaro LJ.
Coffen DL.
J. Org. Chem.
1992,
57:
851
<A NAME="RZ09403SS-6B">6b </A>
Takahashi T.
Muraoka M.
Capo M.
Koga K.
Chem. Pharm. Bull.
1995,
43:
1821
<A NAME="RZ09403SS-7">7 </A>
Matsuki K.
Sobukawa M.
Kawai A.
Inoue H.
Takeda M.
Chem. Pharm. Bull.
1993,
41:
643
<A NAME="RZ09403SS-8A">8a </A>
Rossey G,
Tixidre A,
Wick A, and
Zard L. inventors; Synthelabo, Jpn Patent 4-217969.
<A NAME="RZ09403SS-8B">8b </A>
Yamada S.
Morimatsu K.
Yoshioka R.
Osaki Y.
Seko H.
Tetrahedron: Asymmetry
1998,
9:
1713
<A NAME="RZ09403SS-9A">9a </A>
Gentile A.
Giordano C.
J. Org. Chem.
1992,
57:
6635
<A NAME="RZ09403SS-9B">9b </A>
Inoue H.
Matsuki K.
Oh-Ishi T.
Chem. Pharm. Bull.
1993,
41:
1521
<A NAME="RZ09403SS-9C">9c </A>
Matsumae H.
Douno H.
Yamada S.
Nishida T.
Ozaki Y.
Shibatani T.
Tosa T.
J. Ferment. Bioeng.
1995,
79:
29
<A NAME="RZ09403SS-9D">9d </A>
Desai SB.
Argade N.
Ganesh KN.
J. Org. Chem.
1996,
61:
6730
Reviews:
<A NAME="RZ09403SS-10A">10a </A>
Genet J.-P. In
Reductions in Organic Synthesis, ACS Symposium Series 641
Magid A.
American Chemical Society;
Washington DC:
1996.
p.31
<A NAME="RZ09403SS-10B">10b </A>
Genet J.-P. In
Advances in Aymmetric Synthesis
Stephenson GR.
Chapman and Hall;
London:
1996.
p.60
<A NAME="RZ09403SS-10C">10c </A>
Ratovelomanana-Vidal V.
Genet J.-P.
J. Organomet. Chem.
1998,
567:
163
<A NAME="RZ09403SS-11A">11a </A>
Poupardin O.
Greck C.
Genet J.-P.
Tetrahedron Lett.
2000,
41:
8795
<A NAME="RZ09403SS-11B">11b </A>
Dolls DA.
Vanhessche KPM.
Brazi E.
Rautenstrauch V.
Lenoir J.-Y.
Genet J.-P.
Wiles J.
Bergens SH.
Angew. Chem. Int. Ed.
2000,
39:
1992
<A NAME="RZ09403SS-12A">12a </A>
Noyori R.
Ikeda T.
Ohkuma T.
Widhalm M.
Kitamura M.
Takaya H.
Akutagawa S.
Sayo N.
Saito T.
Taketomi T.
Kumobayashi H.
J. Am. Chem. Soc.
1989,
111:
9134
<A NAME="RZ09403SS-12B">12b </A> Review:
Noyori R.
Tokunaga M.
Kitamura M.
Bull. Chem. Soc. Jpn.
1995,
68:
36
<A NAME="RZ09403SS-12C">12c </A> Review:
Ratovelomanana-Vidal V.
Genet J.-P.
Can. J. Chem.
2000,
78:
846
<A NAME="RZ09403SS-13A">13a </A>
Genet J.-P.
Pinel C.
Mallart S.
Juge S.
Thorimbert S.
Laffitte JA.
Tetrahedron: Asymmetry
1991,
2:
555
<A NAME="RZ09403SS-13B">13b </A>
Girard A.
Greck C.
Ferroud D.
Genet J.-P.
Tetrahedron Lett.
1996,
37:
7967
<A NAME="RZ09403SS-13C">13c </A>
Coulon E.
Cano de Andrade MC.
Ratovelomanana-Vidal V.
Genet J.-P.
Tetrahedron Lett.
1998,
39:
6467
<A NAME="RZ09403SS-13D">13d </A>
Phansavath P.
Duprat de Paule S.
Ratovelomanana-Vidal V.
Genet J.-P.
Eur. J. Org. Chem.
2000,
3903
<A NAME="RZ09403SS-14">14 </A>
Genet J.-P.
Pfister X.
Ratovelomanana-Vidal V.
Pinel C.
Laffitte JA.
Tetrahedron Lett.
1994,
35:
4559
<A NAME="RZ09403SS-15">15 </A>
Lavergne D.
Mordant C.
Ratovelomanana-Vidal V.
Genet J.-P.
Org. Lett.
2001,
3:
1909
<A NAME="RZ09403SS-16A">16a </A>
Sayo N,
Sano N, and
Kumobayachi H. inventors; Takasago, European Patent 0519763A2.
<A NAME="RZ09403SS-16B">16b </A>
Genet J.-P.
Cano de Andrade MC.
Ratovelomanana-Vidal V.
Tetrahedron Lett.
1995,
36:
2063
<A NAME="RZ09403SS-17">17 </A> The choice of the configuration of the ligand follows the general sense of the
asymmetric induction:
Kitamura M.
Ohkuma T.
Inoue S.
Sayo N.
Kumobayashi H.
Akutagawa S.
Ohta T.
Takaya H.
Noyori R.
J. Am. Chem. Soc.
1988,
110:
629
<A NAME="RZ09403SS-18">18 </A>
Genet J.-P.
Pinel C.
Ratovelomanana-Vidal V.
Mallart S.
Pfister X.
Caño de Andrade MC.
Laffitte JA.
Tetrahedron: Asymmetry
1994,
5:
665